JFL Life Sciences IPO – Review, Bid, Size, Allotment, Subscription, GMP & RHP
Last Updated Date: Nov 17, 2022Let’s have a detailed review of the company and analytics of the JFL Life Sciences IPO release date, IPO offer price, subscription, JFL Life Sciences Limited IPO allotment, grey market price, and other details like the company’s background, its financial positions, its promoters, and other related things.
| Face Value | Rs 10 |
| Price Band | Rs. 61 per share |
| Listing At | NSE SME |
| Min. Order Quantity | 2000 shares |
| Listing Date | Sep 8, 2022 |
| Offer for Sale | – |
| Fresh Issue | Rs. 1,816.58 Lakhs |
| IPO Size | Rs. 1,816.58 Lakhs |
| Tick Size | 1 |
JFL Life Sciences IPO is listed at a [●] premium. Check out the live share price by clicking on the below link.
JFL Life Sciences IPO – Summary
They Company was incorporated as ‘JFL Life Sciences Private Limited’ on April 25, 2010 as a private limited company under the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli.
Pursuant to a special resolution of our Shareholders passed in the extra-ordinary general meeting held on February 10, 2022, They
Company was converted from a private limited company to public limited company and consequently, the name of our Company was changed to ‘JFL Life Sciences Limited’, and a fresh certificate of incorporation dated March 3, 2022 was issued to our Company by the Registrar of Companies, Gujarat at Ahmedabad. The corporate identification number of our Company is U24230GJ2010PLC060417.
The Promoter of this company is SMIRAL ASHWINKUMAR PATEL AND TEJAL SMIRAL PATEL. The lead manager to the issue is GYR CAPITAL ADVISORS PRIVATE LIMITED, and the Registrar to this issue is KFIN TECHNOLOGIES LIMITED.
JFL Life Sciences IPO Date
The opening of JFL Life Sciences IPO will be on Aug 25, 2022 and the closing date Aug 30, 2022.
JFL Life Sciences IPO Subscription
| Day / Date | NII | RII | Total Subscription |
| 1st Day – 25th Aug | 0.24x | 0.75x | 0.49x |
| 2nd Day – 26th Aug | 0.51x | 1.65x | 1.08x |
| 3rd Day – 29th Aug | 0.66x | 3.71x | 2.19x |
| 4th Day – 30th Aug | 6.19x | 11.66x | 8.93x |
| Shares Offered or Net Issue | 1,414,000 | 1,414,000 | 2,828,000 |
The shares subscribed by the public will be updated here.
JFL Life Sciences IPO Allotment Status
Here, you can find the Allotment Status of this IPO.
Allotment of Equity Shares pursuant to the Fresh Issue and transfer of the Offered Shares of the Promoter Selling Shareholders pursuant to the Offer for Sale to the successful Bidders. However, the Allotment Status is not yet disclosed.
JFL Life Sciences Limited IPO Listing Date
Find the dates below on basis of allotment, refund, listing, and more:
| Basis of Allotment Finalization | Sep 5, 2022 |
| Refunds Initiation | Sep 6, 2022 |
| Credit of Shares to Demat Account | Sep 7, 2022 |
| Share Listing Date | Sep 8, 2022 |
JFL Life Sciences IPO Price Band
The face value of each share is Rs.10, but the price band of the IPO is Rs.61.
JFL Life Sciences IPO Equity Size
This Initial Public Issue of 2,978,000 Equity Shares of Rs.10 each for cash at a price of Rs.61 per equity share aggregating to Rs. 1,816.58 Lakhs.
JFL Life Sciences IPO Share Offering
Fresh Issue: The Issue (excluding the Market Maker Reservation Portion) of 28,28,000 Equity Shares of Rs.10/ each.
Issue Size: Rs. 2,978,000 Equity Shares of Rs.10 each, aggregating to Rs. 1,816.58 Lakhs.
Open Free Demat Account Now!
JFL Life Sciences IPO – Live Performance
The listing date of this IPO is Sep 5, 2022. You can check the live performance of the IPO here, only after it is listed on exchanges.
| Live IPO Performance – JFL Life Sciences Share Price |
JFL Life Sciences IPO Grey Market Premium
The JFL Life Sciences Limited IPO Grey Market Premium price is Rs 5, the Kostak rate is Rs X and the Subject to Sauda is 20000.
JFL Life Sciences IPO – Company Overview
Headquartered in Ahmedabad, Gujarat, our company is engaged in the business of manufacturing of pharmaceutical products. Our product portfolio consists of Dry powder injections ( B-Lactam ), Tablets & Capsules (B-Lactam) solid oral dosage form and Tablet and capsules (general) Solid Oral Dosage Form and Oral rehydration solutions (ORS).
Our company is engaged in domestic as well as international business. With market presence in PAN India, products of JFL is supplied to 10 developed and developing countries throughout the World.
To maintain its competitiveness and to further the cause of health care JFL has laid a strong R&D foundation and a FDA approved state of the art manufacturing facility near Ahmedabad.
We are a manufacturing company, so our sales strategy is to sell our products in bulk to pharmaceuticals marketers and traders who in turn provide the channel for sales to customers. We do not sell it under any brand name and we use the same strategy for both domestic & international market.
JFL Life Sciences IPO – Financial Statements
A quick look into the past financial performance of the company to understand its performance of the business and evaluate the growth prospectus:
Financial Summary:
| Amount (in INR & Lakh) | ||||
| 28-Feb-22 | 31-Mar-21 | 31-Mar-20 | 31-Aug-19 | |
| Total Assets | 3662.86 | 2900.69 | 2432.59 | 1614.96 |
| *Total Revenue | 2563.06 | 3286.89 | 3020.41 | 3177.96 |
| Total Expense | 2,222.05 | 3,212.23 | 2,970.71 | 3,135.68 |
| Profit After Tax | 253.28 | 54.21 | 36.04 | 30.25 |
Earnings per Equity Share (in Lakh)
| 28-Feb-22 | 31-Mar-21 | 31-Mar-20 | 31-Aug-19 | |
| Basic & Diluted | 3.77 | 0.89 | 0.66 | 0.59 |
Further, their PAT for the period ended on,28-Feb-22, 31-Mar-21, 31-Mar-20, and 31-Aug-19 were Rs.253.28 Lakh, Rs.54.21 Lakh, Rs. 36.04 Lakh and Rs.30.25 Lakh, respectively.
JFL Life Sciences IPO – Promoters
The Promoter of this company is:
- SMIRAL ASHWINKUMAR PATEL
- ATEJAL SMIRAL PATEL
List of Related Parties (Key Managerial Personnel)
- Smiral Ashwinkumar Patel, Managing Director
- Tejal Smiral Patel, Whole-time Director
- Manishkumar Jasvantlal Patel, Chairman and Non-Executive Director
- Sonu Lalitkumar Jain, Independent Director
- Bhavna Shah, Independent Director
- Pratima Singh, Company Secretary
- Bhaumik Sanjaykumar Shah, Chief Financial Officer
JFL Life Sciences IPO – Promoters Holding
- Pre Issue Share Holding – 92.52%
- Pos Issue Share Holding – 67.47%
JFL Life IPO Offer Details or Issue Details
| Particulars | No. Of Equity Shares |
| Equity Shares Offered | Up to 2,978,000 Equity Shares aggregating up to Rs. 1,816.58 Lakhs |
| of which: | |
| Issue Reserved for the Market Makers | Up to 1,50,000 Equity Shares aggregating up to Rs.91.50 Lakh |
| Net Issue to the Public | Up to 28,28,000 Equity Shares aggregating up to Rs. 1,725.08 Lakh |
| Of which: | |
| Retail Investors Portion | Not less than 50% |
| Other than Retail Individual Investors | Not more than 50% |
| Equity Shares outstanding prior to the Issue | 80,20,441 Equity Shares |
| Equity Shares outstanding after the Issue | 1,09,98,441 Equity Shares |
JFL Life Sciences IPO Issue Object
Their Company proposes to utilize the Net Proceeds towards funding the following objects:
- Repayment of secured and unsecured loans.
- Funding the working capital requirements of the company.
- General Corporate Purposes
JFL Life Sciences IPO – Business Strategy
- Geographical diversification
- Improve production capacity
- Continue to focus on operational excellence
- Enhancing our customer base
JFL Life IPO – Basis of Offer Price
The issue price is determined by the company in consultation with the Lead manager on the basis of the following qualitative and quantitative factors.
Qualitative factors are:
- Experienced Promoters and Management Expertise
- Quality Customer Base
- Quality and focus on customer satisfaction
- Satisfactory track record
The relevant quantitative factors are:
| Basic & Diluted EPS | RONW (%) | NAV (Rs.) | |
| 28-Feb-22 | 3.77 | 25.20 | 13.67 |
| 31-Mar-21 | 0.89 | 7.89 | 138.29 |
| 31-Mar-20 | 0.66 | 6.70 | – |
| 31-Aug-19 | 0.59 | 6.03 | – |
JFL Life IPO: Competitive Peers
| Face Value (Rs.) | P/E | EPS (Rs.) | Return on Net Worth (%) | Total Income (Rs. in Lakhs) | |
| JFL Life Sciences Limited | 10 | 16.18 | 3.77 | 7.18 | 2563.06 |
| Listed Peers | |||||
| Zenith Health Care Limited | 1 | 102.75 | 0.058 | 4.54 | 2,288.35 |
| Vaishali Pharma Limited | 10 | 23.37 | 3.82 | 17.95 | 7760.89 |
JFL Life Sciences IPO Lead Managers
| Lead Managers |
| GYR CAPITAL ADVISORS PRIVATE LIMITED (Formerly known as Alpha Numero Services Private Limited) CIN: U67200GJ2017PTC096908 428, Gala Empire, Near T.B. Tower Drive In Road, Thaltej, Ahmedabad – 380054, Gujarat, India Tel No.: +91 87775 64648 Fax No.: N.A. Email:info@gyrcapitaladvisors.com Website:www.gyrcapitaladvisors.com Investor Grievance Email:info@gyrcapitaladvisors.com Contact Person: Mohit Baid SEBI Registration No.: INM000012810 |
JFL Life Sciences IPO Registrar to offer
| Registrar to the Offer |
| KFIN TECHNOLOGIES LIMITED (Formerly known as KFin Technologies Private Limited) CIN: U72400TG2017PLC117649 Selenium Tower-B, Plot 31 & 32, Gachibowli, Financial District, Nanakramguda, Serilingampally, Hyderabad – 500 032, Telangana Contact Person : M Murali Krishna Tel: +91 40 6716 2222 Fax: +91 40 2343 1551 Email: jfl.ipo@kfintech.com Investor Grievance Email: einward.ris@kfintech.com Website: www.kfintech.com SEBI Registration No. : INR000000221 |
JFL Life Sciences IPO – Other Details
- Statutory Auditor – M/s. Doshi Doshi & Co
- Legal Counsel to the Company – T&S Law
- Bankers to the Company – State Bank of India
JFL Life IPO Review by Stock Brokers
| Top Stock Brokers Review | Company Reputation | Competitive Edge | Financial Statement | Popularity Index | Promoters Reputation |
| Angel Broking | 7.5/10 | 7.4/10 | 8.5/10 | 8.1/10 | 7.1/10 |
| Sharekhan | 7.2/10 | 7.1/10 | 8.6/10 | 8.1/10 | 7.2/10 |
| Kotak Securities | 7.3/10 | 7.5/10 | 8.4/10 | 8.1/10 | 7.3/10 |
| ICICI Direct | 7.3/10 | 7.3/10 | 8.7/10 | 8.1/10 | 7.1/10 |
| IIFL | 7.5/10 | 7.2/10 | 8.8/10 | 8.0/10 | 7.1/10 |
| Edelweiss | 7.5/10 | 7.4/10 | 8.4/10 | 8.3/10 | 7.2/10 |
| Zerodha | 7.4/10 | 7.1/10 | 8.5/10 | 8.1/10 | 7.0/10 |
| 5Paisa | 7.1/10 | 7.1/10 | 8.4/10 | 8.1/10 | 7.1/10 |
| Karvy | 7.4/10 | 7.3/10 | 8.2/10 | 8.1/10 | 7.1/10 |
| Motilal Oswal | 7.1/10 | 7.1/10 | 8.6/10 | 8.3/10 | 7.2/10 |
Subscribe to JFL Life Sciences IPO
JFL Life Sciences Limited IPO News
News 1 – IPO DRHP Download
News 2 – IPO RHP Prospectus Download
JFL Life Sciences IPO Review FAQs
Check out various FAQs related to JFL Life Sciences IPO:
What is the Issue Size of JFL Life Sciences IPO?
The Company is making an initial public offer of 2,978,000 equity shares. We vividly portray the aspects of the issue in this article. You can check the stats on the fresh issue, Offer for sale, and the net issue.
What is the Price band of JFL Life Sciences IPO?
The price band for this particular IPO ranges between Rs. 61. As far as the face value of the share is of concern, it is Rs.10 per share.
What is the JFL Life Sciences IPO Open Date?
The opening and closing dates for this IPO have been updated. The IPO is set to open on Aug 25, 2022, while the closing date is set at Aug 30, 2022.
What is the JFL Life Sciences IPO Allotment Date?
We also have the news regarding the respective allotment dates of this IPO. Basis of Allotment finalization is on Sep 5, 2022, refund initiation is on Sep 6, 2022, credit of shares is on Sep 7, 2022, and share listing date is on Sep 8, 2022.
What is the JFL Life Sciences IPO Listing Date?
Shares of this company shall be listed in the exchanges Sep 8, 2022. The date, when the listing would be done, is stagnant on Sep 8, 2022.
Who is the Registrar of JFL Life IPO?
One of the reputed registrars is managing the issue of this IPO, KFin Technologies Limited. Their website will help you regarding the further information you are on the lookout for.
Who is the Promoter of JFL Life Sciences IPO?
Here are the promoters of this IPO – SMIRAL ASHWINKUMAR PATEL AND TEJAL SMIRAL PATEL. You can refer to the RHP for further information on the promoter. You will find the link to RHP in the article.
What is GMP of JFL Life IPO?
We have obtained the GMP of this IPO and it is 5. Further insights of Kostak rate and subject to sauda 20000 or SS are as well included in this report.
Is JFL Life IPO good for Investment?
We have further provided the financial status of the company in this article, from the past few years. You can refer to the same, and also check the line of operations they are into and then decide to invest in the IPO.
What is the PAT of JFL Life Sciences Company?
We have the information of company financials, and according to that, we have the figures from the last few years to provide. PAT for the period ended on,28-Feb-22, 31-Mar-21, 31-Mar-20, and 31-Aug-19 were Rs.253.28 Lakh, Rs.54.21 Lakh, Rs. 36.04 Lakh and Rs.30.25 Lakh, respectively.
Calculate your return on investment!
Asset Class
ROI (Rs.)
Profit (Rs.)
Profit (%)
IPO
Equity
Savings
Real Estate
Gold
Bonds
Fixed Deposit
Mutual Fund
Featured Topics